Myocardial Perfusion Imaging With 99m Tc Tetrofosmin Comparison to 201 Tl Imaging and Coronary Angiography in a Phase III Multicenter Trial

• Published in: Circulation (New York, N.Y.) Vol. 91; no. 2; pp. 313 - 319
• Main Authors: Zaret, Barry L., Rigo, Pierre, Wackers, Frans J.T., Hendel, Robert C., Braat, Simon H., Iskandrian, Ami S., Sridhara, Bangalore S., Jain, Diwakar, Itti, Roland, Serafini, Aldo N., Goris, Michael L., Lahiri, Avijit
• Format: Journal Article
• Language: English
• Published: 15.01.1995
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/01.CIR.91.2.313

Background Our objective was to compare the sensitivity and specificity of tetrofosmin, a new 99m Tc-labeled myocardial perfusion imaging agent for the detection of myocardial perfusion abnormalities, with those of 201 Tl and coronary angiography. Our hypothesis was that same-day stress/rest tetrofosmin imaging could provide data comparable to those of 201 Tl imaging. Myocardial perfusion imaging plays an important role for the evaluation of coronary artery disease. Newer 99m Tc-labeled agents offer several advantages over 201 Tl, the conventional myocardial perfusion imaging agent. Tetrofosmin is a new 99m Tc-labeled agent with promising results in preliminary studies. Methods and Results Two hundred fifty-two patients with suspected coronary artery disease were enrolled in 10 centers in the United States and Europe. All patients underwent exercise and rest myocardial perfusion imaging with 99m Tc-tetrofosmin using two separate injections of the radiotracer 4 hours apart on the same day. Planar images were obtained in three standard views 15 to 60 minutes after radiotracer injection. Patients also underwent standard exercise and redistribution planar 201 Tl imaging within 2 weeks of tetrofosmin imaging. In addition, 58 healthy subjects with low likelihood of coronary artery disease underwent exercise and rest tetrofosmin imaging. Coronary angiograms were available in 181 patients with suspected coronary artery disease. All radionuclide images were processed in the central core laboratory and interpreted blindly by a panel of four experienced readers. 201 Tl images and tetrofosmin images were read separately. Discrepancies were resolved by consensus. The workload, peak heart rate, and double products were comparable during exercise for both imaging agents. Technically acceptable paired 201 Tl and tetrofosmin images were available in 224 of 252 patients. Tetrofosmin images were generally of good quality, with low extracardiac activity, and easy to interpret. Patients were categorized as showing normal, ischemia, infarction, or mixture with each imaging modality. Precise concordance for each of these categories was 59.4% (κ=0.44; 95% CI, 0.35 to 0.53). When patients were categorized as normal or abnormal, the concordance was 80.4% (κ=0.55; 95% CI, 0.43 to 0.67). When each of five anatomic territories (septal, anterior, inferior, lateral, and apical) was categorized as normal versus abnormal, the concordance varied from 81% to 90%. When similar comparison was made for the specific category of abnormality, the concordance was 64% to 84%. When coronary angiography was used as the criterion, the sensitivity and positive and negative predictive accuracy of tetrofosmin and 201 Tl were comparable. The normalcy rate of tetrofosmin images in the healthy subjects with low likelihood of coronary artery disease was 97%. Conclusions 99m Tc tetrofosmin is a new myocardial imaging agent with favorable imaging characteristics with results comparable to those of 201 Tl.